cysteamine has been researched along with ergoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szabo, S | 1 |
| Reichlin, S; Szabo, S | 1 |
| Besouw, MT; Levtchenko, EN; Noordam, K; Willemsen, MA | 1 |
3 other study(ies) available for cysteamine and ergoline
| Article | Year |
|---|---|
Dopamine disorder in duodenal ulceration.
Topics: Animals; Anti-Ulcer Agents; Apomorphine; Bromocriptine; Chemical Phenomena; Chemistry; Cysteamine; Dopamine; Drug Synergism; Duodenal Ulcer; Ergolines; Female; Gastric Juice; Haloperidol; Pimozide; Rats; Receptors, Dopamine | 1979 |
Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists.
Topics: Animals; Bromocriptine; Cysteamine; Duodenum; Ergolines; Female; Hypothalamus; Pancreas; Rats; Rats, Inbred Strains; Somatostatin; Stomach; Vagotomy | 1983 |
Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?
Topics: Administration, Oral; Administration, Topical; Body Height; Cabergoline; Child; Cysteamine; Cystinosis; Dopamine Agonists; Ergolines; Headache; Human Growth Hormone; Humans; Male; Ophthalmic Solutions; Pituitary Neoplasms; Prolactinoma; Radiation-Protective Agents; Treatment Outcome | 2008 |